Structure

Physi-Chem Properties

Molecular Weight:  596.3
Volume:  611.858
LogP:  4.309
LogD:  3.496
LogS:  -5.43
# Rotatable Bonds:  11
TPSA:  121.64
# H-Bond Aceptor:  9
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.169
Synthetic Accessibility Score:  5.926
Fsp3:  0.647
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.325
MDCK Permeability:  3.78074255422689e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.031
20% Bioavailability (F20%):  0.763
30% Bioavailability (F30%):  0.565

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.032
Plasma Protein Binding (PPB):  79.68339538574219%
Volume Distribution (VD):  2.392
Pgp-substrate:  13.708911895751953%

ADMET: Metabolism

CYP1A2-inhibitor:  0.028
CYP1A2-substrate:  0.093
CYP2C19-inhibitor:  0.41
CYP2C19-substrate:  0.384
CYP2C9-inhibitor:  0.919
CYP2C9-substrate:  0.01
CYP2D6-inhibitor:  0.26
CYP2D6-substrate:  0.035
CYP3A4-inhibitor:  0.938
CYP3A4-substrate:  0.788

ADMET: Excretion

Clearance (CL):  9.265
Half-life (T1/2):  0.258

ADMET: Toxicity

hERG Blockers:  0.836
Human Hepatotoxicity (H-HT):  0.914
Drug-inuced Liver Injury (DILI):  0.362
AMES Toxicity:  0.012
Rat Oral Acute Toxicity:  0.884
Maximum Recommended Daily Dose:  0.951
Skin Sensitization:  0.097
Carcinogencity:  0.063
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.978

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471169

Natural Product ID:  NPC471169
Common Name*:   12-Deacetoxy-12-(2-Methylbutanoxyl)Toonacilin
IUPAC Name:   [(1aR,3S,3aR,4R,5R,6R,7aS)-5-acetyloxy-3-(furan-3-yl)-6-[(1S,6R)-6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-methylbutanoate
Synonyms:  
Standard InCHIKey:  DONYQPIDLOHRDV-NAQGJSFCSA-N
Standard InCHI:  InChI=1S/C34H44O9/c1-10-18(2)30(38)42-29-28(41-20(4)35)27(32(7)13-11-24(36)31(5,6)23(32)16-26(37)39-9)19(3)34-25(43-34)15-22(33(29,34)8)21-12-14-40-17-21/h11-14,17-18,22-23,25,27-29H,3,10,15-16H2,1-2,4-9H3/t18?,22-,23-,25+,27+,28+,29-,32-,33+,34+/m0/s1
SMILES:  CCC(C(=O)O[C@H]1[C@H](OC(=O)C)[C@@H](C(=C)[C@@]23[C@]1(C)[C@@H](C[C@H]3O2)c1cocc1)[C@@]1(C)C=CC(=O)C([C@@H]1CC(=O)OC)(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2386295
PubChem CID:   71725940
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10033 Turraea pubescens Species Meliaceae Eukaryota twig Dongfang, Hainan Province, China 2010-Mar PMID[23734701]
NPO10033 Turraea pubescens Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 20000.0 nM PMID[465049]
NPT116 Cell Line HL-60 Homo sapiens IC50 < 10000.0 nM PMID[465049]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471169 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC175964
0.9932 High Similarity NPC471175
0.9605 High Similarity NPC5741
0.9477 High Similarity NPC471166
0.9477 High Similarity NPC471167
0.94 High Similarity NPC84063
0.929 High Similarity NPC471168
0.9167 High Similarity NPC472669
0.9103 High Similarity NPC472668
0.8987 High Similarity NPC259943
0.8974 High Similarity NPC474932
0.8889 High Similarity NPC469848
0.8831 High Similarity NPC116717
0.8765 High Similarity NPC472650
0.8758 High Similarity NPC476224
0.8742 High Similarity NPC197596
0.8726 High Similarity NPC204663
0.869 High Similarity NPC242068
0.869 High Similarity NPC247563
0.8684 High Similarity NPC34056
0.8671 High Similarity NPC469847
0.8671 High Similarity NPC195131
0.8654 High Similarity NPC322546
0.8654 High Similarity NPC29695
0.8654 High Similarity NPC182427
0.8654 High Similarity NPC308205
0.8642 High Similarity NPC472764
0.8606 High Similarity NPC471632
0.859 High Similarity NPC291150
0.859 High Similarity NPC18135
0.8589 High Similarity NPC327922
0.8589 High Similarity NPC472765
0.8589 High Similarity NPC472766
0.858 High Similarity NPC105395
0.8571 High Similarity NPC255414
0.8571 High Similarity NPC476197
0.8553 High Similarity NPC167142
0.8553 High Similarity NPC470118
0.8553 High Similarity NPC197137
0.8544 High Similarity NPC469850
0.8535 High Similarity NPC268905
0.8526 High Similarity NPC5180
0.8509 High Similarity NPC472767
0.8509 High Similarity NPC6326
0.8503 High Similarity NPC478177
0.8494 Intermediate Similarity NPC94763
0.8494 Intermediate Similarity NPC477824
0.8485 Intermediate Similarity NPC285227
0.8476 Intermediate Similarity NPC242334
0.8462 Intermediate Similarity NPC470790
0.8462 Intermediate Similarity NPC470791
0.8462 Intermediate Similarity NPC69647
0.8462 Intermediate Similarity NPC471001
0.8462 Intermediate Similarity NPC125182
0.8457 Intermediate Similarity NPC165218
0.8438 Intermediate Similarity NPC214495
0.8438 Intermediate Similarity NPC475066
0.8438 Intermediate Similarity NPC470119
0.8428 Intermediate Similarity NPC476262
0.8428 Intermediate Similarity NPC92979
0.8424 Intermediate Similarity NPC472659
0.8418 Intermediate Similarity NPC472672
0.8415 Intermediate Similarity NPC173516
0.8408 Intermediate Similarity NPC156189
0.8395 Intermediate Similarity NPC96443
0.8395 Intermediate Similarity NPC470939
0.8395 Intermediate Similarity NPC290400
0.8393 Intermediate Similarity NPC470181
0.8387 Intermediate Similarity NPC471292
0.8385 Intermediate Similarity NPC475226
0.8385 Intermediate Similarity NPC473473
0.8385 Intermediate Similarity NPC472671
0.8385 Intermediate Similarity NPC475295
0.8383 Intermediate Similarity NPC236004
0.8365 Intermediate Similarity NPC302054
0.8365 Intermediate Similarity NPC253201
0.8364 Intermediate Similarity NPC160651
0.8364 Intermediate Similarity NPC472673
0.8364 Intermediate Similarity NPC471397
0.8354 Intermediate Similarity NPC149945
0.8354 Intermediate Similarity NPC478178
0.8344 Intermediate Similarity NPC472139
0.8344 Intermediate Similarity NPC469846
0.8333 Intermediate Similarity NPC167340
0.8333 Intermediate Similarity NPC221809
0.8333 Intermediate Similarity NPC469633
0.8333 Intermediate Similarity NPC191828
0.8323 Intermediate Similarity NPC286722
0.8323 Intermediate Similarity NPC195954
0.8323 Intermediate Similarity NPC472283
0.8313 Intermediate Similarity NPC264943
0.8303 Intermediate Similarity NPC476850
0.8303 Intermediate Similarity NPC476861
0.8303 Intermediate Similarity NPC478179
0.8302 Intermediate Similarity NPC476201
0.8293 Intermediate Similarity NPC469849
0.8293 Intermediate Similarity NPC476856
0.8293 Intermediate Similarity NPC476858
0.8293 Intermediate Similarity NPC476857
0.8291 Intermediate Similarity NPC469335
0.8291 Intermediate Similarity NPC159927
0.8282 Intermediate Similarity NPC472771
0.8282 Intermediate Similarity NPC470792
0.8274 Intermediate Similarity NPC471437
0.8274 Intermediate Similarity NPC469576
0.8272 Intermediate Similarity NPC237155
0.8269 Intermediate Similarity NPC470999
0.8263 Intermediate Similarity NPC159232
0.8261 Intermediate Similarity NPC60973
0.8261 Intermediate Similarity NPC209364
0.8258 Intermediate Similarity NPC199044
0.8258 Intermediate Similarity NPC238843
0.8247 Intermediate Similarity NPC121158
0.8242 Intermediate Similarity NPC470875
0.8235 Intermediate Similarity NPC56197
0.8232 Intermediate Similarity NPC14499
0.8232 Intermediate Similarity NPC469338
0.8232 Intermediate Similarity NPC663
0.8232 Intermediate Similarity NPC224394
0.8232 Intermediate Similarity NPC476035
0.8232 Intermediate Similarity NPC292389
0.8232 Intermediate Similarity NPC475039
0.8232 Intermediate Similarity NPC472773
0.8228 Intermediate Similarity NPC329180
0.8221 Intermediate Similarity NPC472653
0.8221 Intermediate Similarity NPC470789
0.8221 Intermediate Similarity NPC305016
0.8221 Intermediate Similarity NPC25255
0.8217 Intermediate Similarity NPC471174
0.821 Intermediate Similarity NPC88007
0.821 Intermediate Similarity NPC299038
0.8205 Intermediate Similarity NPC5676
0.8204 Intermediate Similarity NPC470995
0.8199 Intermediate Similarity NPC141538
0.8199 Intermediate Similarity NPC155939
0.8199 Intermediate Similarity NPC296807
0.8194 Intermediate Similarity NPC80635
0.8193 Intermediate Similarity NPC472774
0.8193 Intermediate Similarity NPC472282
0.8193 Intermediate Similarity NPC473753
0.8193 Intermediate Similarity NPC473766
0.8193 Intermediate Similarity NPC472775
0.8193 Intermediate Similarity NPC476853
0.8187 Intermediate Similarity NPC75906
0.8187 Intermediate Similarity NPC33938
0.8187 Intermediate Similarity NPC470996
0.8187 Intermediate Similarity NPC471002
0.8182 Intermediate Similarity NPC62692
0.8182 Intermediate Similarity NPC61967
0.8182 Intermediate Similarity NPC27541
0.8182 Intermediate Similarity NPC123088
0.8182 Intermediate Similarity NPC476860
0.8182 Intermediate Similarity NPC276551
0.8182 Intermediate Similarity NPC126984
0.8182 Intermediate Similarity NPC470940
0.8176 Intermediate Similarity NPC476122
0.8176 Intermediate Similarity NPC477404
0.8176 Intermediate Similarity NPC470997
0.8176 Intermediate Similarity NPC196864
0.8171 Intermediate Similarity NPC68848
0.8171 Intermediate Similarity NPC193798
0.8171 Intermediate Similarity NPC329938
0.8171 Intermediate Similarity NPC117986
0.8171 Intermediate Similarity NPC149896
0.816 Intermediate Similarity NPC477403
0.8148 Intermediate Similarity NPC126723
0.8148 Intermediate Similarity NPC107646
0.8148 Intermediate Similarity NPC263265
0.8141 Intermediate Similarity NPC251865
0.8137 Intermediate Similarity NPC57998
0.8137 Intermediate Similarity NPC98206
0.8137 Intermediate Similarity NPC237259
0.8137 Intermediate Similarity NPC34421
0.8133 Intermediate Similarity NPC472141
0.8133 Intermediate Similarity NPC307781
0.8133 Intermediate Similarity NPC23387
0.8133 Intermediate Similarity NPC472670
0.8125 Intermediate Similarity NPC272590
0.8125 Intermediate Similarity NPC471000
0.8121 Intermediate Similarity NPC285567
0.8121 Intermediate Similarity NPC234660
0.8121 Intermediate Similarity NPC51568
0.8113 Intermediate Similarity NPC234494
0.8113 Intermediate Similarity NPC472654
0.811 Intermediate Similarity NPC477402
0.811 Intermediate Similarity NPC475381
0.8101 Intermediate Similarity NPC216755
0.8101 Intermediate Similarity NPC71821
0.8098 Intermediate Similarity NPC472778
0.8098 Intermediate Similarity NPC472772
0.8098 Intermediate Similarity NPC472777
0.8098 Intermediate Similarity NPC173544
0.8098 Intermediate Similarity NPC187149
0.8098 Intermediate Similarity NPC472776
0.8098 Intermediate Similarity NPC194499
0.8095 Intermediate Similarity NPC88593
0.8086 Intermediate Similarity NPC469336
0.8084 Intermediate Similarity NPC270312
0.8081 Intermediate Similarity NPC470938
0.8077 Intermediate Similarity NPC223415

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471169 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7975 Intermediate Similarity NPD5761 Phase 2
0.7975 Intermediate Similarity NPD5760 Phase 2
0.7784 Intermediate Similarity NPD8434 Phase 2
0.7701 Intermediate Similarity NPD6765 Approved
0.7701 Intermediate Similarity NPD6764 Approved
0.7679 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD6784 Approved
0.7528 Intermediate Similarity NPD6785 Approved
0.7086 Intermediate Similarity NPD8127 Discontinued
0.7049 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD4628 Phase 3
0.6946 Remote Similarity NPD7236 Approved
0.6936 Remote Similarity NPD7819 Suspended
0.6923 Remote Similarity NPD6273 Approved
0.6923 Remote Similarity NPD7685 Pre-registration
0.6889 Remote Similarity NPD7799 Discontinued
0.686 Remote Similarity NPD6599 Discontinued
0.6856 Remote Similarity NPD7497 Discontinued
0.6842 Remote Similarity NPD7239 Suspended
0.6836 Remote Similarity NPD5494 Approved
0.6824 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6798 Remote Similarity NPD1247 Approved
0.6784 Remote Similarity NPD920 Approved
0.678 Remote Similarity NPD919 Approved
0.6766 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6758 Remote Similarity NPD5844 Phase 1
0.6743 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6728 Remote Similarity NPD8032 Phase 2
0.6726 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6723 Remote Similarity NPD7075 Discontinued
0.6705 Remote Similarity NPD8443 Clinical (unspecified phase)
0.67 Remote Similarity NPD8404 Phase 2
0.6667 Remote Similarity NPD642 Clinical (unspecified phase)
0.6647 Remote Similarity NPD6005 Phase 3
0.6647 Remote Similarity NPD5763 Approved
0.6647 Remote Similarity NPD643 Clinical (unspecified phase)
0.6647 Remote Similarity NPD5762 Approved
0.6647 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6647 Remote Similarity NPD6004 Phase 3
0.6647 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6647 Remote Similarity NPD6002 Phase 3
0.6629 Remote Similarity NPD7411 Suspended
0.6627 Remote Similarity NPD3748 Approved
0.6612 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6611 Remote Similarity NPD7199 Phase 2
0.661 Remote Similarity NPD3817 Phase 2
0.6609 Remote Similarity NPD3226 Approved
0.6608 Remote Similarity NPD6799 Approved
0.6591 Remote Similarity NPD6801 Discontinued
0.659 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6587 Remote Similarity NPD2796 Approved
0.6573 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6571 Remote Similarity NPD7028 Phase 2
0.657 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6559 Remote Similarity NPD6559 Discontinued
0.6557 Remote Similarity NPD7473 Discontinued
0.6548 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6548 Remote Similarity NPD1471 Phase 3
0.6538 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6531 Remote Similarity NPD4107 Approved
0.6514 Remote Similarity NPD7458 Discontinued
0.651 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6503 Remote Similarity NPD7852 Clinical (unspecified phase)
0.648 Remote Similarity NPD8285 Discontinued
0.648 Remote Similarity NPD7058 Phase 2
0.648 Remote Similarity NPD7057 Phase 3
0.6471 Remote Similarity NPD1243 Approved
0.6461 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6446 Remote Similarity NPD6355 Discontinued
0.6442 Remote Similarity NPD6832 Phase 2
0.6433 Remote Similarity NPD4110 Phase 3
0.6433 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6433 Remote Similarity NPD3750 Approved
0.6425 Remote Similarity NPD5402 Approved
0.6414 Remote Similarity NPD4482 Phase 3
0.6407 Remote Similarity NPD6653 Approved
0.6406 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6404 Remote Similarity NPD1934 Approved
0.6402 Remote Similarity NPD8312 Approved
0.6402 Remote Similarity NPD8313 Approved
0.6398 Remote Similarity NPD1876 Approved
0.6395 Remote Similarity NPD3887 Approved
0.6393 Remote Similarity NPD6232 Discontinued
0.6392 Remote Similarity NPD17 Approved
0.6391 Remote Similarity NPD2438 Suspended
0.6391 Remote Similarity NPD6100 Approved
0.6391 Remote Similarity NPD6099 Approved
0.6389 Remote Similarity NPD4966 Approved
0.6389 Remote Similarity NPD4965 Approved
0.6389 Remote Similarity NPD4967 Phase 2
0.6387 Remote Similarity NPD8150 Discontinued
0.6386 Remote Similarity NPD4140 Approved
0.6384 Remote Similarity NPD4380 Phase 2
0.6383 Remote Similarity NPD8368 Discontinued
0.6379 Remote Similarity NPD2534 Approved
0.6379 Remote Similarity NPD2532 Approved
0.6379 Remote Similarity NPD2533 Approved
0.6375 Remote Similarity NPD3972 Approved
0.6368 Remote Similarity NPD8407 Phase 2
0.6364 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6359 Remote Similarity NPD3926 Phase 2
0.6358 Remote Similarity NPD3267 Approved
0.6358 Remote Similarity NPD3266 Approved
0.6354 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6344 Remote Similarity NPD3751 Discontinued
0.6344 Remote Similarity NPD3818 Discontinued
0.6335 Remote Similarity NPD5327 Phase 3
0.6333 Remote Similarity NPD5353 Approved
0.6331 Remote Similarity NPD2799 Discontinued
0.633 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6324 Remote Similarity NPD2403 Approved
0.6322 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6319 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6319 Remote Similarity NPD6234 Discontinued
0.6316 Remote Similarity NPD970 Clinical (unspecified phase)
0.6313 Remote Similarity NPD37 Approved
0.631 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6307 Remote Similarity NPD5403 Approved
0.6298 Remote Similarity NPD3882 Suspended
0.6298 Remote Similarity NPD7768 Phase 2
0.6294 Remote Similarity NPD1551 Phase 2
0.6286 Remote Similarity NPD5401 Approved
0.6286 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6279 Remote Similarity NPD2800 Approved
0.6278 Remote Similarity NPD2801 Approved
0.6277 Remote Similarity NPD7074 Phase 3
0.6273 Remote Similarity NPD1608 Approved
0.6265 Remote Similarity NPD3268 Approved
0.6264 Remote Similarity NPD3749 Approved
0.6257 Remote Similarity NPD6386 Approved
0.6257 Remote Similarity NPD2346 Discontinued
0.6257 Remote Similarity NPD6385 Approved
0.6256 Remote Similarity NPD7907 Approved
0.625 Remote Similarity NPD6959 Discontinued
0.625 Remote Similarity NPD5735 Approved
0.625 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6243 Remote Similarity NPD8166 Discontinued
0.6237 Remote Similarity NPD6166 Phase 2
0.6237 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6237 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6236 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6235 Remote Similarity NPD7033 Discontinued
0.6228 Remote Similarity NPD6663 Approved
0.6226 Remote Similarity NPD5585 Approved
0.6223 Remote Similarity NPD7054 Approved
0.6223 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6221 Remote Similarity NPD1549 Phase 2
0.622 Remote Similarity NPD5647 Approved
0.6216 Remote Similarity NPD7315 Approved
0.6216 Remote Similarity NPD3787 Discontinued
0.6216 Remote Similarity NPD6808 Phase 2
0.6213 Remote Similarity NPD6353 Approved
0.6199 Remote Similarity NPD2935 Discontinued
0.6193 Remote Similarity NPD7410 Clinical (unspecified phase)
0.619 Remote Similarity NPD2979 Phase 3
0.619 Remote Similarity NPD7472 Approved
0.619 Remote Similarity NPD4307 Phase 2
0.6188 Remote Similarity NPD8455 Phase 2
0.6188 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6188 Remote Similarity NPD1465 Phase 2
0.6183 Remote Similarity NPD5242 Approved
0.6178 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6178 Remote Similarity NPD7808 Phase 3
0.6173 Remote Similarity NPD7507 Approved
0.6171 Remote Similarity NPD6652 Clinical (unspecified phase)
0.617 Remote Similarity NPD7228 Approved
0.6163 Remote Similarity NPD2353 Approved
0.6163 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6163 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6163 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6161 Remote Similarity NPD4111 Phase 1
0.6159 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6159 Remote Similarity NPD6008 Approved
0.6159 Remote Similarity NPD7319 Approved
0.6159 Remote Similarity NPD6362 Approved
0.6154 Remote Similarity NPD8360 Approved
0.6154 Remote Similarity NPD1241 Discontinued
0.6154 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6154 Remote Similarity NPD8435 Approved
0.6154 Remote Similarity NPD8361 Approved
0.6149 Remote Similarity NPD7003 Approved
0.6143 Remote Similarity NPD5980 Discovery
0.6139 Remote Similarity NPD3057 Approved
0.6134 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6129 Remote Similarity NPD7229 Phase 3
0.6127 Remote Similarity NPD7999 Approved
0.6126 Remote Similarity NPD7251 Discontinued
0.6118 Remote Similarity NPD6651 Approved
0.6114 Remote Similarity NPD6190 Approved
0.6108 Remote Similarity NPD7435 Discontinued
0.6098 Remote Similarity NPD8651 Approved
0.6087 Remote Similarity NPD1778 Approved
0.6085 Remote Similarity NPD4665 Approved
0.6084 Remote Similarity NPD5736 Approved
0.6082 Remote Similarity NPD7097 Phase 1
0.6077 Remote Similarity NPD6873 Phase 2
0.6073 Remote Similarity NPD6797 Phase 2
0.6071 Remote Similarity NPD2313 Discontinued
0.6071 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6066 Remote Similarity NPD5616 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data